Untitled

Monk, Terri G.

doi:10.1186/cc2824

Cited by 23 publications

(5 citation statements)

References 48 publications

(49 reference statements)

Supporting

Mentioning

Contrasting

Order By: Relevance

“…Nevertheless these criteria might be questioned in respect of preoperative anemia management. If the transfusion risk is estimated to exceed 10%, patients with an Hb level of between 10 and 13 g/dL should be considered for iron-/ESA-substitution [5]. Present data confirm this recommendation.…”

Section: Discussionsupporting

confidence: 59%

“…On the other hand allogenic blood units will become scarce and more expensive because of decreasing donation rates and increasing production costs [1, 3, 5, 32]. …”

Section: Discussionmentioning

confidence: 99%

“…The prevalence of preoperative anemia is positively correlated with the age of the patient and more often found in elderly patients [2, 5]. Anemia of chronic disease (ACD) and iron deficiency (ID) are the most frequent causes of preoperative anemia [2, 6].…”

Section: Introductionmentioning

confidence: 99%

“…Low preoperative hemoglobin (Hb) levels are well known as major predicting factors in requiring perioperative blood transfusion in orthopedic surgery [7, 8]. Patients with preoperative Hb levels between 10 and 13 g/dL may be more often transfused than those with Hb level > 14 g/dL [5, 9]. …”

Section: Introductionmentioning

confidence: 99%

“…The preoperative treatment of anemia was based on the Thomas-plot [13–16]. A threshold of 13 g/dL Hb was used as a cut-off for diagnostic and therapeutic intervention for men as well as women based on published data [5, 17]. This proposed diagnostic strategy was compared with the published Network for Advancement of Transfusion Alternatives (NATA) guidelines [10, 18].…”

Section: Introductionmentioning

confidence: 99%

See 4 more Smart Citations

The Impact of an Algorithm-Guided Management of Preoperative Anemia in Perioperative Hemoglobin Level and Transfusion of Major Orthopedic Surgery Patients

Enko

Wallner

von-Goedecke³

et al. 2013

Anemia

View full text Add to dashboard Cite

The aim of this study was to evaluate a laboratory-guided therapeutic algorithm of preoperative anemia. 335 patients with elective hip or knee arthroplasty were included in this retrospective before-after study. Group I (n = 101) underwent conventional preoperative procedures before algorithm implementation. Group II (n = 234) underwent algorithm-guided preoperative anemia management. A hemoglobin-level of 13 g/dL was the therapeutic cut-off for men and women. Reticulocyte hemoglobin content (CHr) and soluble transferrin receptor (sTfR)/log ferritin ratio were used in the form of the Thomas plot. Iron deficiency (ID) was substituted with 1000 mg iron intravenous (i.v.) and 10000 international units (I.U.) of erythropoiesis-stimulating agent (ESA) subcutaneous (s.c.) or i.v., anemia of chronic disease (ACD) (without functional ID) with 40000 I.U. ESA s.c. or i.v and additionally 200 mg iron i.v. Substituted anemic patients in Group II (n = 32) showed a distinctly higher preoperative (Hb-median 13 versus 11.95 g/dL) (P < 0.01) and postoperative (Hb-median 9.75 versus 9.0 g/dL) (P < 0.05) Hb level compared with untreated anemic patients in Group I (n = 24). In Group II red blood cell (RBC) units (35 units/234 patients) were reduced by 44% compared with Group I (27 units/101 patients). Algorithm-guided preoperative anemia management raises perioperative Hb-level and reduces blood use.

show abstract

Section: Discussionsupporting

confidence: 59%

“…On the other hand allogenic blood units will become scarce and more expensive because of decreasing donation rates and increasing production costs [1, 3, 5, 32]. …”

Section: Discussionmentioning

confidence: 99%

Section: Introductionmentioning

confidence: 99%

Section: Introductionmentioning

confidence: 99%

Section: Introductionmentioning

confidence: 99%

See 3 more Smart Citations

The Impact of an Algorithm-Guided Management of Preoperative Anemia in Perioperative Hemoglobin Level and Transfusion of Major Orthopedic Surgery Patients

Enko

Wallner

von-Goedecke³

et al. 2013

Anemia

View full text Add to dashboard Cite

show abstract

Anemia and Cardiovascular Disease

Manolis¹,

Koulouris²,

Triantafyllou³

et al. 2010

Alternatives to Blood Transfusion in Transfusion Medicine

View full text Add to dashboard Cite

Treatment of individuals who cannot receive blood products for religious or other reasons

et al. 2017

View full text Add to dashboard Cite

By virtue of their religious principles, Jehovah's Witnesses (JWs) generally object to receiving blood products, raising numerous ethical, legal, and medical challenges for providers who care for these patients, especially in the emergent setting. In this review, we discuss several areas relevant to the care of JWs, including the current literature on "bloodless" medical care in the setting of perioperative and intraoperative management, acute blood loss, trauma, pregnancy, and malignancy. We have found that medical and administrative efforts in the form of bloodless medicine and surgery programs can be instrumental in helping to reduce risks of morbidity and mortality in these patients. Planning prior to an anticipated event associated with blood loss or anemia (such as elective surgery, pregnancy, and chemotherapy) is critical. Specifically, bloodless medicine programs should prioritize vigilant early screening and management of anemias, early establishment of patient wishes regarding transfusion, and the incorporation of those wishes into multidisciplinary medical and surgical care. Although there are now a variety of human-based and nonhuman-based products available as transfusion alternatives, the degree and quality of evidence to support their use varies significantly between products and is also largely dependent on the clinical setting.

show abstract

Untitled

Cited by 23 publications

References 48 publications

The Impact of an Algorithm-Guided Management of Preoperative Anemia in Perioperative Hemoglobin Level and Transfusion of Major Orthopedic Surgery Patients

The Impact of an Algorithm-Guided Management of Preoperative Anemia in Perioperative Hemoglobin Level and Transfusion of Major Orthopedic Surgery Patients

Anemia and Cardiovascular Disease

Treatment of individuals who cannot receive blood products for religious or other reasons

Contact Info

Product

Resources

About